Revenue

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
HIV Revenue	7.51B	7.09B	Log In	Log In	Log In	Upgrade
Respiratory, Immunology and Inflammation Revenue	3.63B	3.30B	Log In	Log In	Log In	Upgrade
Oncology Revenue	1.82B	1.41B	Log In	Log In	Log In	Upgrade
Pandemic Revenue	-	-	Log In	Log In	Log In	Upgrade
Specialty Medicines Revenue	12.97B	11.81B	Log In	Log In	Log In	Upgrade
Shingles Revenue	3.40B	3.36B	Log In	Log In	Log In	Upgrade
Meningitis Revenue	1.57B	1.44B	Log In	Log In	Log In	Upgrade
Influenza Revenue	328.00M	408.00M	Log In	Log In	Log In	Upgrade
Established Vaccines Revenue	3.23B	3.34B	Log In	Log In	Log In	Upgrade
Pandemic Vaccines Revenue	-	-	Log In	Log In	Log In	Upgrade
Vaccines Revenue	9.08B	9.14B	Log In	Log In	Log In	Upgrade
Respiratory Revenue	7.09B	7.21B	Log In	Log In	Log In	Upgrade
Other General Medicines Revenue	3.03B	3.22B	Log In	Log In	Log In	Upgrade
General Medicines Revenue	10.12B	10.43B	Log In	Log In	Log In	Upgrade
Total Commerical Operations Revenue	32.17B	31.38B	Log In	Log In	Log In	Upgrade
Revenue (Total)	-	31.38B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
US Revenue	16.74B	16.38B	Log In	Log In	Log In	Upgrade
Europe Revenue	7.22B	6.67B	Log In	Log In	Log In	Upgrade
International Revenue	8.20B	8.33B	Log In	Log In	Log In	Upgrade
Revenue (Total)	-	31.38B	Log In	Log In	Log In	Upgrade

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Commercial Operations Segment Profit	15.86B	15.34B	Log In	Log In	Log In	Upgrade
Research & Development Segment Profit	-6.10B	-5.85B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-	4.02B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.